Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.

Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. Abstract Text:

    u veronesiU Veronesi,g berettaG Beretta,

    Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. Publishing Authors By Initials

    u veronesiU Veronesi,g berettaG Beretta,

    For similar organic chemicals: triazenes research abstracts see: organic chemicals: triazenes research

    PUBMED ID PMID:

    MEDLINE DATE:

    Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Recent results in cancer research. Fortschritte de

    VOLUME: 68

    Page Numbers: 375-9

    Journal Abbreviation: Recent Results Cancer Res.

    ISSN: 0080-0015

    DAY: 13

    MONTH: 02

    YEAR: 1978

    Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 44671

    Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. Keywords Mesh Terms:

    KEYWORDS: Triazenes

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report. Information

    Substance Name: Dacarbazine

    Registry Number: 4342-03-4

    Grant and Affiliation Information for Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.

    AFFILIATION:

    Country: GERMANY, WEST

    GERMANY, WEST Research PublicationGERMANY, WEST Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Recent Results Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma Trial 6: preliminary report Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News